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In this study we investigated in rat liver the expression of genes coding for the core proteins of fbromodulin, lumican and aggrecan. By means 
of Northern analysis and in situ hybridization we prcscnt evidence for their differential transcription during liver flbrogenesis. Whereas no 
libromodulin expression could been detected, both lumican and aggrecan transcripts were found displaying different ime-courses ofexpression 
during the Abrogcnic process. Based on studies performed in non-hepatic tissues, these protcoL$ycans are considered to have kcratan sulphatc 
glycooaminoglycan side chains. The expression of the respcctivt core protein genes in liver is unexpected since published ata have shown neither 
keratan sulphate nor its synthesis de novo in this tissue. The results also point to a putative role ofaggreEan i  the modulation of the intlammatory 
process in the liver. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Available studies upport the notion that liver tissue 
is devoid of the expression of keratan suiphate gly- 
cosaminoglycans. The presence of keratan sulphate 
could not be demonstrated by means of the classical 
analyticaixhemical procedures [l-3] and only trace 
amounts of de novo synthesis of a keratan suiphate-like 
glycosaminoglycan have been reported several years 
ago [4-J. Furthermore, recent immunocytochemical stud- 
ies failed to demonstrate the synthesis of this special 
type of giycosaminoglycan in cultured rat liver fat-stor- 
ing cells [S] which have been identified previously as the 
major contributor to glycosaminoglycan production in 
the liver [6-81. By use of Northern blot hybridization, 
in situ hybridization and RNase protection assay we 
were able to detect expression of genes encoding lumi- 
can and aggrecan core proteins in the healthy rat liver 
and during various stages of the development of thio- 
acetamide-induced liver fibrosis. The results are surpris- 
ing since these proteoglycans are considered to have 
keratan suiphate chains as deduced from their structure 
in non-liver tissues [Q-l I]. It is suggested that aggrecan, 
the most abundant (large aggregating) proteogiycan in 
cartilage where its core protein is densely substituted 
with many keratan sulphate and chondroitin. sulfate 
chains is present also in normal and fibrotic liver albeit 
with an altered carbohydrate structure. 
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2.1. AllirHafs 
Female virgin Uje:WIST rats (University ofkna, Germany). initial 
age 3 months, initial body weight 150 g, 3 animals pr group, were 
maintuined on a standard chow diet (type YTD-1, Berlin-Biesenthal, 
Germany). Lighting was kept constant a II 12-h light/dark cycle. For 
induction of fibrosis 0.03% (w/v) of thioacetamide (TAA; Merck AG, 
Darmstadt, Germany) was administered in drinking water for a max- 
imum of 3 months without withdrawal prior to sacrifice 1121. At 2 
weeks, I, 2 nnd 3 months since the onset of TAA treatment a group 
of animals was sacrificed, liver tissue was shock-frozen in liquid N2 
and stored at -SO°C until use. 
2.2. u”crrornic DNA extruction and Southern irartsjtir 
Genomic rat DNA was extracted according to thcmetbod of Wood- 
head et 31. [13]. IOpg pr lane were digested with different restriction 
enzymes (EcoRI, HindlIt and BumHI, all from Ciibco BRL. Berlin, 
Germany) and separated by agarose gel electrophoresls. After dcpuri- 
nation and dcnaturation by standard procedures, gels were transferred 
to Hybond-N membrane (Amersham-Buchler, Braunschwcig, Gcr- 
many) by vacuum transfer (TransYac, Hoefcr, 5an Francisco, USA). 
Hybridization and washing of the filters were performed according to 
Church and Gilbert [14]. 
2.3. Total RNA esrractiorr md Northem blot unn!,sris 
Total RNA was extracted from frozen liver tissue cmploylng the 
gttanidinium isothiocyanatc method and centrifugation through CsCl 
gradient as described by Chirgwin et al. [Is]. Extracted total RNA (25 
lug per lane) was separated lcctrophoretically on fonnamidclfomtal- 
dchyde-agarose g ls. transferred to Hybond-N membrane and hybrid- 
ized with [3’P]dCTt~-labellcd cDNA probes ([a-“P~CTP, 3000 Gil 
mmol; NEN-DuPont, Drcicich, Germany) of specific nclivity 
> I x I04cptn/~g, concentmtion z+ I x IO* cpm/ral hybridization solu- 
tion, 31 6SaC for 48 h. Blots were washed atstringencies vrrying as 
indicated for 3 given experiment. For Northern blot analysis, entire 
cDNAs of chicken lumican (donation of J. Hassell, Univ. of Pcnnsyl- 
sania. USA) and of bovine fibromodulin (gift of A. Oldberg, Univ. 
of Lund, Sweden) were used as probes. 
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2.4. In sitlt I~ybridixtion 
2.4.1. Probes 
cDNA for rat aggrecan was provided by K.L. Drchcr (Wcis Center 
for Research, Danvillc, USA). The cDNA fragmenl was subcloned 
into the pBSK-KS II vector (Stratagene Cloning Systems, La Jolla, 
USA); construction of the probe isshown in Fig. I. After linearization 
of the plasmid with appropriate restriction cndonucleascs singlc- 
stranded RNA probes complcmuntary (anti-sense probe) and anti- 
complementary (sense probe; negative control) to the corresponding 
gene transcripts were obtained by in vitro transcription using T3 and 
T? polymerascs (Stratagene Cloning Systems). The probe was labcllcd 
with [a-3sS]CTP (IOOO-1500 Ci/mmol, NEN-DtiPont) to a specific 
activity of > 5 x IO” cpm/flg, 
2.42. Hybridization and autoradiography 
Serial cryostat sections, uniform thickness 8 pm. were lyophilized 
at -70°C for 2 h, then fixed in 4% panlformaldehyde/PBS, pH 7.4, for 
IO min. at 4’C. Prior to hybridization slides were acetyloted in 0.5% 
of ncetic anhydride in 0.1 M tricthanolaminc. pH 8.0, for 10 mill at 
room tcmpraturc, rinsed in 2 x SSC and air-dried. 
In situ hybridization was performed as described by Tecott et al. 
[16]. In brief, sections were prchybridired at 52°C fnr 2 h in 50% 
formnmide/O.O?. M Tris, pH 7.5/O-3 M NaCX0.001 M EDTA/O.I M 
dithiothreitol/l x Denhtlrdt’s olution/O.5 mg per ml yenst RNAI0.I 
mg per ml poly(A)/O.S mg per ml sonicated salmon sperm DNA. 
Hybridization was carried out at 2X below the c;dculalcd r, in 0.05 
ml of mixture per section (composition as described above, with dex- 
tran sulphatc added to a final concentration of 10% and 1 x IO6 cpm 
of the radioactively labelled probe). After I6 h of incubation slides 
were rinsed in 4x SSCIO.02 MB-mercaptoethanol at room temperature 
followed by a stringency wash in hybridization buffer lacking dextran 
sulphate, lab&d probe, t-RNA, poly(A) and salmon sperm DNA, at 
S°C under the T,, calculated, for IO min. Decrease of the bxkground 
due to non+pccitic binding was achieved by a 30 min digestion of 
mismatched sequences with RNase A (0.02 mdml) and RNase Tl 
(2500 Kunitz U/ml), at 37”C, in 0.5 M N&l/0.01 M Tris, pH 7.5/0.001 
M ECTA. After R wash (30 min at 37OC) in this bulI’er in the absence 
of the enzymes and a brief rinse in 2 x SSC, the slides were subjected 
to a second stringency wash in 0.1 x SSC, at 50°C for I5 min, with 
suusequent equilibration in 0,l x SSC at room temperature. 
Air-dried slides were dipped into NTB 2 nuclear emulsion (Kodak- 
Path& Paris, France) and exposed for I I days at 4°C. Development 
was performed with Kodak DI9 developer, for 2 min; afterwards, 
slides were rinsed in I% acetic acid and fixed in ADEFO fixer 
(ADEFO, Nuremberg, Germany) Ibr I5 min. After extcnsivc washing 
in distilled water, slides were counter-stained with Cresyl violet, air- 
dried, cleared in xylol for IO min and mounted in Entellan (Merck AG, 
Darmsladt, Germany). Sections were evaluated both by bright-field 
transmission and dark-tield reflectance microscopy (Nikon Epiphot). 
2.5 ttiut~urrocytoch~rrlisrry 
Monoclonal antibody BMA 0370 (Bochringcr-Mannheim, Gcr- 
many) detecting human macrophages was used. The APAAP staining 
method as described by Cordell et al. [17] was applied. 
3. RESULTS 
Based on the results obtained, fibromodulin is shown 
to be a single-copy gene in the rat eenome (Fig. 2). The 
homology to its bovine counterpart is greater than 80% 
- washing of the rat genomic blot at stringencies up to 
0.2 x SSC/O.l% SSC at 65°C for 30 min did not remove 
the signals. No hybridization with the liver tissue RNA 
could be demonstrated ( ata not shown). 
The mRNA for lumican, also represented by a single- 
copy gene in the rat genome, has a homology of only 
about 60% to the chicken homologue (Fig. 3A). Wash- 
ing at a stringency of 2 x SSC/O. 1% SDS at 65OC for 30 
min completely removed the signals observed at the 
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Fig. I. Graphic description of the aggrecan cDNA construct used for in situ hybridization showing the gene structure. Emply bars representing 
the ORF of the gene, shaded bars the fragment subcloned. Direction of the subcloning with respect to T, / T, is depicted by use of an arrowhead. 
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Fig. 2. Genomic blot of fibromodulin. IOpg of rat gcnomic DNA each 
were digested with EcQRI (E), FfhdIII (H) and f?a,nNI (U). rcspcc- 
tivcly. Asterisks mark the cross-hybridization of the fibromodulin 
probe with satellite DNA. 
genomic as well as Northern blots. Weak hybridization 
signals of an almost constant intensity throughout he 
time-course of the fibrotic process could be detected in 
the rat liver tissue (Fig. 3B). A control RNA extracted 
From whole rat eyes revealed a closely spaced doublet 
OF approximately 1.3 kb in length. The lumican probe 
from liver hybridized to the upper part of this doublet. 
In normal liver tissue, aggrecan expressing cells are 
found scattered predominantly in, the vicinity of the 
Glisson’s capsule (Fig. 4). Their proportion as well as 
the intensity of the signal increase during the acute in- 
flammatory phase OF the liver damage, i.e. within the 
first two weeks of TAA treatment. Expressing 1~11s are 
localized bordering the periportal fields, more rarely 
close to the orifices of large branches of the portal vein. 
During the following repair phase the expression i ten- 
sity decreases continuously but remains present even in 
fully developed bridging fibrosis at the interface be- 
tween the septa and the proliferating nodes and at the 
limiting plate. The immunocytochemical staining per- 
formed in parallel with the monoclonal antibody BMA 
0370 (marker for human sessile tissue macrophages, 
reacts with Kupffer cells of the rat liver) showed good 
correlation up to 2 months of TAA treatment. In the 
later phase, characterized histomorphologically by 
transition to cirrhosis, divergence occurred. Cells of the 
limiting plate of small regeneration odes showed 
strong hybridization signals whereas no immunostain- 
ing was present. This may be caused by the loss of 
antigenic epitopes of the expressing cells. Alternatively, 
other cell types, e.g. certain subtype(s) of the hepato- 
cytes, start expressing aggrecan at this time point. 
4. DISCUSSION 
Although keratan sulphate is considered to be absent 
from liver tissue [l-3], we present evidence that genes 
coding For proteoglycans described as keratan sulphate- 
bearing are expressed inrat liver. Moreover, this expres- 
sion seems to be regulated differentially during the 
course of liver fibrosis. This apparent discrepancy might 
have several possible explanations. First, it is possible 
that analytical-chemical methods applied to detect kera- 
tan sulphate Failed to do so due to their relatively low 
sensitivity. Second, biglycan and decorin have been re- 
ported to possess varying glycosaminoglycan chains de- 
pending on the kind of the tissue investigated [18]. Thus, 
it might be possible that lumican and/or fibromodulin, 
belonging to the same gene family, do possess carbohy- 
drate chains in the liver other than keratan sulphate. 
For aggrecan, in contrast, varying lengths of the hy- 
aluronic acid (hyaluronan) binding region (MABR), the 
site of attachment of keratan sulphate side chains, have 
been described in different species. In rat, this region is 
distinctly shorter or even missing compared to other 
species tudied [9]. Thus, rat liver tissue may truly be 
depleted of keratan sulphate, although core proteins of 
proteoglycans described as keratan sulphate-substituted 
in other tissues are indeed present. Although there is 
transcription present, a putative translation block also 
cannot be ruled out. Further investigation will elucidate 
which hypothesis gains more support. 
As already mentioned, fibromodulin, lumican, bigly- 
can and decorin arc supposed to have arisen from a 
common ancestral gene [10,11,19]. Both biglycan and 
decorin are expressed in the rat liver, albeit at different 
basal levels, with an increase paralleling the develop- 
ment of fibrosis [20]. Eumican is also expressed in the 
rat liver, but at quite constant levels throughout the 
fibrotic process. This finding is concordant with that of 
Blochbcrger et al. [l 11, who found low expression levels 
of lumican in healthy chicken liver. The observation 
that lumican hybridizes in rat liver to the upper part of 
a closely spaced doublet compared to the RNA ex- 
tracted from whole rat eyes (similarly to the observa- 
tions described in chicken) is most probably due to a 
differential splicing of lumican mRNA with predomi- 
nant occurrence of one of both splicing types pecific for 
the tissue given. Investigations are under way to detect 
the rat homologue of the lumican gene, to determine the 
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Fig. 3. Genomic blot of lumican (A) and the appropriate Northern blot (B) depicting the time-course of lumican expression ilt various stages of 
the cle~~loprnent of liver fibrosis (NL = norm~ll liver; following he-points in months, i.e. 0.3, I, 2 and 3; A = whole rat eyes). Abbreviations used 
for the genomic blot are as in Fig. 2. 
expressing cell type(s) and to resolve the spatial expres- 
sion pattern by means of in situ hybridization. 
On the contrary, no detectable fibromodulin expres- 
sion was found in rat liver. One possible xplanation is
that the expression levels of this proteoglycan lie below 
the sensitivity limit of Northern blotting, Alternatively, 
ra& liver can be truly devoid of fibromodulin expression, 
which would support he hypothesis that irrespective of
the structural similarities proteoglycans are differen- 
tially regulated and exert quite specialized functions de 
pending on the kind of tissue and, eventually, even on 
the developmental stage, 
Aggrecs?n was detected by means of in situ hybridiza- 
tion in the Kupffer cells of the liver. Its levels of expres- 
sion are extremely ow ill the healthy tissue but increase 
during a narrow period of acute inflammatory response 
to toxic liver damage. Low amounts, restricted to the 
ceiis iocaiized at the iimicing plate of proliferating 
nodes, remain detectable until the development of cir- 
rhosis. Based on preliminary results obtained by an 
RNase protestion assay, the expressing ceii type is the 
Kupffer sell. This finding is of particular interest: 
though aggrecan has been described as the major consti- 
tutive proteoglycan of the bone matrix and cartilage 
and put in connection with their aberrant development 
[21,22], no aggrecan expression has been reported so far 
in liver tissue or in connection with the inflammatory 
process. In this context, lhough not wishing to overin- 
tcrpret he observation, certain facts concerning the mo- 
lecular organization of aggrecan could allow insight 
into its probably multifunctional nature. Aggrecan has 
been described as a molecule possessing distinct struc- 
tural domains; whether these domains are capable of 
independent function is not clear. The molecular organ- 
ization of its G3 domain resembles that of a group of 
cell adhesion molecules, known as ‘LIXXMs’ [B], 
which are involved in mediating and modulation of in- 
flammatory processes. From the parallel with the induc- 
tion of aggrecan expression during the inflammatory 
phase as well as these structural properties it is tempting 
to postulate a possible involvement of aggrecan i  the 
modulation of the inflammatory reaction following 
liver injury. Further experimental work will clarify the 
question of the mode of induction of aggrecan expres- 
s&n as well as the levels of aggrecan translation, The 
ligand involved will also have to be identified. Should 
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our hypothesis prove correct, aggrecan could be a good 
target for medical intervention in terms of controlling 
the inflammatory conditions in acutely injured liver. 
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